The Alliance For Benzodiazepine Best Practices
- Assets
- $56.5k
- Revenue
- $273.4k
- Investments
- $0.0
- Employees
- 0
- Location
- Portland, OR
- Founding
- Data as of
- 12/2020
- EIN
- 82-4973519
Organization Overview
The Alliance For Benzodiazepine Best Practices is located in Portland, OR. According to its NTEE Classification (H05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alliance For Benzodiazepine Best Practices is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, Alliance For Benzodiazepine Best Practices generated $273.4k in total revenue. This organization has experienced exceptional growth, as over the past 2 years, it has increased revenue by an average of 22.2% each year . All expenses for the organization totaled $217.1k during the year ending 12/2020. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2020
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCHED MEDICAL LITERATURE, CONDUCTED AND ANALYZED STUDIES, AND PUBLISHED ARTICLES ON BENZODIAZEPINES. 4 PAPERS PUBLISHED IN MAJOR SCIENTIFIC JOURNALS.
COMPLETED ORIGINAL LAB RESEARCH (AN ANIMAL STUDY) ON BENZODIAZEPINES; CONTRACTED TO AND DONE AT THE UNIVERSITY OF ARIZONA; PAPER WRITTEN AND SUBMITTED FOR PUBLICATION ON THE MECHANISMS BEHIND THE DEVELOPMENT OF BENZODIAZEPINE WITHDRAWAL SYNDROME. 2 MORE PAPERS BEING WRITTEN.
CONTINUE TO DELIVER A CONTINUING MEDICAL EDUCATION SERIES ON THE RISK AND BENEFIT TRADE-OFFS OF BENZODIAZEPINES; DONE AT MEDICAL VENUES ALL ACROSS THE USA. 14 CME CLASSES DELIVERED IN 2020 TO OVER 1000 PRESCRIBERS.
SPECIFIED, COORDINATED AND OVERSAW THE WRITING OF A PRESCRIBER-DIRECTED BOOK THAT COLLECTS ALL OF THE PERTINENT INFORMATION ABOUT BENZODIAZEPINES IN THE HOPES OF DECREASING THEIR USE. THE BOOK, "THE BENZODIAZEPINES CRISIS", WAS PUBLISHED IN 2020.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Steven L Wright MD Director | 4 | $0 | |
Arwen Podesta MD Director | 1 | $0 | |
Doryn D Chervin PHD Director | 5 | $0 | |
Richard Bailey Dph Director | 3 | $0 | |
Bernard Silvernail Director, President | 40 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Nema Research Inc | 12/30/20 | $57,880 |
Steven L Wright Md | 12/30/20 | $116,717 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $265,175 |
| Interest on Savings | $8 |
| Dividends & Interest | $374 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $7,829 |
| Capital Gain Net Income | $7,829 |
| Net ST Capital Gain | $7,829 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $273,386 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $15,320 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $645 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $0 |
| Printing and publications | $0 |
| Other expenses | $70,355 |
| Total operating and administrative expenses | $217,136 |
| Contributions, gifts, grants paid | $0 |
| Total expenses and disbursements | $217,136 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $56,528 |
| Savings and temporary cash investments | $0 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $56,528 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |